Effectiveness and costs of atypical versus typical antipsychotic treatment for schizophrenia in routine care

被引：0
作者：
Stargardt, T.
Weinbrenner, S.
Busse, R.
Juckel, G.
Gericke, C. A.
机构：
[1] Berlin Univ Technol, Berlin, Germany
[2] Ruhr Univ Bochum, Sch Med, D-4630 Bochum, Germany
[3] Univ Adelaide, Adelaide, SA, Australia
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63183-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A196 / A196
页数：1
相关论文
共 50 条
[41]   Effects of typical, atypical, and no antipsychotic drugs on visual contrast detection in schizophrenia [J].
Chen, Y ;
Levy, DL ;
Sheremata, S ;
Nakayama, K ;
Matthysse, S ;
Holzman, PS .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (10) :1795-1801
[42]   Treatment compliance and persistence among schizophrenia patients: Atypical versus typical antipsychotics [J].
Rajagopalan, K ;
Gianfrancesco, F .
SCHIZOPHRENIA BULLETIN, 2005, 31 (02) :549-549
[43]   Safety of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (Europa study) [J].
Bobes, J ;
Ciudad, A ;
Sacristan, JA ;
Alvarez, E ;
Cañas, F ;
Carrasco, JL ;
Gascón, J .
SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) :220-221
[44]   Outpatient antipsychotic treatment and inpatient costs of schizophrenia [J].
Marcus, Steven C. ;
Olfson, Mark .
SCHIZOPHRENIA BULLETIN, 2008, 34 (01) :173-180
[45]   The routine use of atypical antipsychotic agents: Maintenance treatment [J].
Kinon, BJ .
JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 :18-22
[46]   Differential Effects of Atypical versus Typical Antipsychotic Medication on Earnings of Schizophrenia PatientsEstimates from a Prospective Naturalistic Study [J].
David Salkever ;
Eric Slade ;
Mustafa Karakus .
PharmacoEconomics, 2006, 24 :123-139
[47]   Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment [J].
McEvoy, JP ;
Lieberman, JA ;
Stroup, TS ;
Davis, SM ;
Meltzer, HY ;
Rosenheck, RA ;
Swartz, MS ;
Perkins, DO ;
Keefe, RSE ;
Davis, CE ;
Severe, J ;
Hsiao, JK .
AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (04) :600-610
[48]   Typical versus atypical antipsychotics in first episode schizophrenia [J].
Altamura, AC ;
Sassella, F ;
Bassetti, R ;
Mundo, E .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 :S35-S35
[49]   Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment [J].
Gunes, Mehmet ;
Camkurt, Mehmet Akif ;
Bulut, Mahmut ;
Demir, Suleyman ;
Ibiloglu, Aslihan Okan ;
Kaya, Mehmet Cemal ;
Atli, Abdullah ;
Kaplan, Ibrahim ;
Sir, Aytekin .
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2016, 14 (04) :345-350
[50]   RELATIONSHIPS BETWEEN SERUM TOTAL ANTIOXIDANT CAPACITY AND TYPICAL/ATYPICAL ANTIPSYCHOTIC TREATMENT IN ACUTE PARANOID SCHIZOPHRENIA [J].
Diaz-Mesa, E. ;
Morera-Fumero, A. ;
Abreu-Gonzalez, P. ;
Henry-Benitez, M. ;
Fernandez-Lopez, L. ;
Yelmo-Cruz, S. ;
Gracia-Marco, R. .
EUROPEAN PSYCHIATRY, 2014, 29
12345